DUSP10 (Dual Specificity Phosphatase 10), also known as MAPK Phosphatase 5 (MKP5), is a member of the dual-specificity phosphatase family that specifically dephosphorylates and inactivates both JNK (c-Jun N-terminal Kinase) and p38 MAPK pathways. These stress-activated protein kinase pathways are central to cellular responses to inflammatory cytokines, oxidative stress, and environmental toxins—all key contributors to neurodegenerative processes. DUSP10 plays a critical role in resolving neuroinflammation and protecting neurons from stress-induced cell death [1][2].
[^2]
| Property | Value |
|----------|-------|
| Gene Symbol | DUSP10 |
| Gene Name | Dual Specificity Phosphatase 10 |
| Aliases | DUSP10, MKP5, MAPKSP1, CL100, PRTP |
| Chromosomal Location | 1p35.3 |
| NCBI Gene ID | 80824 |
| OMIM | 607070 |
| UniProt | Q9Y263 |
| Ensembl | ENSG00000143507 |
¶ Function and Biochemistry
DUSP10 encodes a 482-amino acid protein with the following key structural features:
- N-terminal Non-catalytic Domain: Contains binding sites for MAPK substrates and regulators
- Phosphatase Catalytic Domain: Contains the HCX5R active site motif essential for phosphatase activity
- Nuclear Export Signal (NES): Allows shuttling between nucleus and cytoplasm
Unlike DUSP1 (MKP1) which is primarily cytosolic, DUSP10 can be found in both nuclear and cytoplasmic compartments [3].
DUSP10 has broad specificity for stress-activated MAP kinases:
- JNK1/2/3: All JNK isoforms are efficiently dephosphorylated
- p38 alpha/beta/gamma: Multiple p38 isoforms are targets
- ERK1/2: Less efficient dephosphorylation compared to JNK/p38
This broad specificity makes DUSP10 a key regulator of cellular stress responses [4].
DUSP10 expression and activity are regulated at multiple levels:
- Transcriptional Induction: Rapidly upregulated by cellular stress
- Post-translational Modification: Phosphorylation affects activity and localization
- Protein-Protein Interactions: Scaffold proteins influence substrate selection
In the central nervous system, DUSP10 is expressed in:
- Microglia: High expression in activated microglia
- Astrocytes: Moderate expression, increased under stress
- Neurons: Lower baseline expression, induced by injury
DUSP10 shows cell-type specific patterns:
- Immune Cells: High expression in macrophages and T cells
- Glial Cells: Induction during neuroinflammation
- Neurons: Stress-induced expression
DUSP10 is a critical regulator of neuroinflammation:
- Microglial Activation: Limits excessive pro-inflammatory cytokine production
- TNF-alpha Signaling: Negatively regulates TNF-induced JNK/p38 activation
- IL-1beta Effects: Modulates IL-1 receptor signaling cascades
- NF-kappaB Cross-talk: JNK/p38 inhibition affects NF-kB dependent transcription [5]
In Alzheimer's disease:
- Amyloid-beta Pathology: A beta oligomers activate JNK and p38 pathways; DUSP10 provides negative feedback
- Tau Phosphorylation: JNK contributes to tau hyperphosphorylation; DUSP10 may modulate this
- Synaptic Dysfunction: JNK activation affects synaptic plasticity; DUSP10 is protective
- Neuronal Apoptosis: Chronic JNK/p38 activation triggers neuronal death; DUSP10 can prevent this [6][7]
In Parkinson's disease:
- Dopaminergic Neuron Survival: JNK/p38 pathways are activated in vulnerable SNc neurons
- Oxidative Stress: 6-OHDA and MPTP activate stress kinases; DUSP10 is neuroprotective
- Neuroinflammation: Microglial JNK/p38 activation contributes to degeneration
- LRRK2 Interaction: LRRK2 mutations affect MAPK signaling [8][9]
In ALS:
- Motor Neuron Degeneration: JNK/p38 activation in motor neurons
- Glutamate Excitotoxicity: Stress kinase pathways contribute to excitotoxic cell death
- Astrocyte Reactivity: DUSP10 dysregulation in reactive astrocytes
- SOD1 Mutations: Mutant SOD1 affects stress kinase signaling [10]
In Huntington's disease:
- Mutant HTT Effects: Huntingtin protein activates JNK/p38 pathways
- Transcriptional Dysregulation: Stress kinases affect gene expression
- Neuronal Dysfunction: DUSP10 may provide neuroprotective effects [11]
DUSP10 represents a promising therapeutic target:
- Anti-inflammatory Strategies: Enhancing DUSP10 could reduce harmful neuroinflammation
- Neuroprotection: Preserving DUSP10 function may protect neurons
- Combination Therapy: Targeting multiple DUSPs may have additive benefits
- Delivery across the blood-brain barrier
- Achieving cell-type specific targeting
- Balancing inflammatory responses (complete inhibition may be detrimental)
DUSP10 genetic variants have been studied in:
- Inflammatory autoimmune diseases
- Various cancers
- Neurodegenerative disease risk
No specific pathogenic mutations causing familial neurodegenerative disease have been definitively linked to DUSP10.
¶ Interactions and Pathways
DUSP10 interacts with:
- JNK1/2/3 isoforms
- p38 MAPK isoforms
- MAPK kinases (MKK4, MKK7)
- Scaffold proteins
DUSP10 participates in:
- JNK signaling cascade
- p38 MAPK pathway
- Inflammatory cytokine signaling
- Stress-activated cell death pathways
¶ Detection and Measurement
- qPCR: Quantifies DUSP10 mRNA levels
- Western Blot: Detects protein and phosphorylation state
- Immunohistochemistry: Localizes DUSP10 in brain tissue
- Phospho-MAPK Assays: Measures substrate activation
- Cell Lines: Neuronal (SH-SY5Y), microglial (BV2), astrocytic (C8-D1A)
- Animal Models: DUSP10 knockout mice
- Post-mortem Brain Tissue: Human studies